We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
20 hedge funds and large institutions have $11M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.59M | |
| 2 | +$345K | |
| 3 | +$271K | |
| 4 |
LPL Financial
San Diego,
California
|
+$206K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$25.2K |
Top Sellers
| 1 | -$658K | |
| 2 | -$320K | |
| 3 | -$236K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$196K |
| 5 |
CA
CoreCap Advisors
Southfield,
Michigan
|
-$121K |